QART Medical

📍 Ra'anana, Israel👥 15 employees💰 Last funded Jun 2019
QART (Quantitative Assisted Reproductive Technologies) Medical, a clinical-stage MedTech company, addressing the global infertility epidemic. The Company develops a breakthrough solution for highly informative characterization and selection of sperm cells for in-vitro fertilization (IVF), aiming to create a new and better gold standard in the ART market. The QART system aims to improve current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by: * Quantitatively characterizing the morphology and contents of individual sperm cells with 3D topographic imaging * Providing quantitative DNA integrity information, on a cell-by-cell basis * Automatically sorting a semen sample according to objective consensus criteria.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography2 countries
Israel
1
United States
1
Frequently asked questions
Who invested in QART Medical?
QART Medical has 2 investors on record on gritt.io.
When did QART Medical last raise funding?
The most recent investment in QART Medical recorded on gritt.io was in June 2019.
What industry is QART Medical in?
QART Medical operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is QART Medical based?
QART Medical is headquartered in Ra'anana, Israel.